Aberdeen Group’s BioLife Solutions BLFS Stock Holding History

Aberdeen Group’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-128,969	Closed	-$2.35M	–	916
2022 Q4	$2.35M	Buy	128,969 +4,007	+3%	+$82.7K	0.01%	687
2022 Q3	$2.84M	Buy	124,962 +2,511	+2%	+$53.7K	0.01%	646
2022 Q2	$1.73M	Sell	122,451 -9,673	-7%	-$142K	0.01%	730
2022 Q1	$3.04M	Buy	132,124 +1,824	+1%	+$48K	0.01%	679
2021 Q4	$4.86M	Hold	130,300	–	–	0.01%	643
2021 Q3	$5.56M	Hold	130,300	–	–	0.01%	634
2021 Q2	$5.81M	Buy	+130,300	New	+$4.59M	0.01%	615

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Aberdeen Group's BLFS Position: Q1 2023 in Review

Aberdeen Group sold out of BioLife Solutions (BLFS) in Q1 2023, closing a stake of 128,969 shares — an estimated $2.35M sold.

Aberdeen Group first reported a position in BLFS in Q2 2021 and held it in 7 quarters. The position peaked at $5.81M in Q2 2021. 169 funds tracked by Wall St. Rank hold BLFS as of Q1 2023.

Aberdeen Group reported no remaining BioLife Solutions position as of Q1 2023 after selling out during the quarter.
Aberdeen Group sold 128,969 BioLife Solutions shares in Q1 2023, an estimated $2.35M.
Aberdeen Group first reported a position in BioLife Solutions in Q2 2021 and held it in 7 quarters.
Aberdeen Group's BioLife Solutions position peaked at $5.81M in Q2 2021.
169 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2023.

Based on Aberdeen Group's 13F filing for Q1 2023, filed 28 Apr 2023.